Navigation Links
West Nile Virus Reported from New York to Long Beach; The Center for the Biology of Chronic Disease (CBCD) Urges the Public to Take Precautions
Date:9/13/2013

Rochester, NY (PRWEB) September 13, 2013

Many people do not think about infection with the West Nile Virus (WNV). However, “As of Sept. 10, 2013, 117 human cases have been reported in 23 California counties, including 66 cases in Los Angeles County (1).” Moreover, “There have been six West Nile virus-related deaths this year in California (1).”

The virus is not limited to California. It is spreading. “For the first time this season, the Health Department has detected West Nile virus in New York City mosquitoes. The infected mosquitoes were collected from the Pomonok neighborhood in Queens and the Huguenot Beach neighborhood on Staten Island (2).”

The CDC says on its website that “West Nile virus (WNV) is most commonly transmitted to humans by mosquitoes (3).” In addition, “The incubation period for WNV disease is typically 2 to 6 days but ranges from 2 to 14 days and can be several weeks in immunocompromised people. An estimated 70-80% of human WNV infections are subclinical or asymptomatic. Most symptomatic persons experience an acute systemic febrile illness that often includes headache, weakness, myalgia, or arthralgia; gastrointestinal symptoms and a … rash also are commonly reported (3).”

Finally, Medscape reports on its website on a page last updated in January, 2012 that “In hospitalized patients in New York City, neurologic sequelae of the West Nile virus included severe muscle weakness, with approximately 10% of patients developing a complete flaccid paralysis. One in 150 West Nile virus infections results in encephalitis or meningitis, and the mortality rate from severe illness is 3-15%. Individuals older than 75 years are at particular risk. As the elderly population increases and the distribution of the West Nile virus spreads nationwide, a growing number of infected individuals may require comprehensive inpatient rehabilitation to overcome the virus's disabling effects (4).”

The CBCD’s Greg Bennett said, “With the West Nile Virus spreading on both coasts, it is important for people to protect themselves. Besides using an approved insect repellant, people should make sure windows have screens to keep mosquitoes out, and they should remove and empty any standing water on their property. We also suggest that people consider taking Gene-Eden-VIR, a natural antiviral product by polyDNA that helps the immune system target latent viruses.”

A recent post marketing clinical study published on August 21, 2013 in the journal Pharmacology & Pharmacy showed that 70% of Gene-Eden-VIR users reported a reduction in viral symptoms. (5)

To learn more about Gene-Eden-VIR, visit: http://www.gene-eden-kill-virus.com.

References:

(1)    http://www.presstelegram.com/health/20130911/long-beach-reports-first-west-nile-virus-case-of-2013
(2)    http://www.nyc.gov/html/doh/html/pr2013/pr023-13.shtml
(3)    http://www.cdc.gov/westnile/healthCareProviders/healthCareProviders-ClinLabEval.html
(4)    http://emedicine.medscape.com/article/312210-overview
(5)    http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

The CBCD is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11117271.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Bacterial protein mops up viruses found in contaminated water supplies
3. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
4. IMDx Obtains CE-Marking for an Automated Molecular Test for Detection and Differentiation of Herpes Simplex Viruses 1 and 2
5. Scientists report successful vaccine developed against deadly Nipah virus
6. Mosquitoes Common in the U.S. Can Transmit Disease-Causing Virus Endemic to Asia
7. JPM-TMT Awards New Contract to Study Administration using Marburg Virus Drug
8. Researchers create laser the size of a virus particle
9. When parasites catch viruses
10. Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
11. Viruses cooperate or conquer to cause maximum destruction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, today announced ... financing and entered into a $5 million credit ... to use the capital for general corporate purposes ... in the treatment of serious diseases treated by ...
(Date:2/16/2017)... , Feb. 16, 2017  Rhythm, ... rare genetic deficiencies that result in life-threatening ... a $41 million mezzanine round of financing ... OrbiMed, MPM Capital, New Enterprise Associates, Pfizer ... undisclosed public healthcare investment fund. Rhythm will ...
(Date:2/15/2017)... ... February 15, 2017 , ... Park Systems , a leader ... AFM operating software that drastically boosts productivity with single click reliable nanoscale images, is ... functions of setting up and taking the image once done manually by the operator ...
(Date:2/15/2017)... Pa. , Feb. 15, 2017 ... a biotechnology company focused on developing aerosolized KL4 ... it has completed a $10.5 million private placement ... that it has sufficient capital to fund its ... clinical trial data release in mid-2017. ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):